256 related articles for article (PubMed ID: 24887455)
21. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.
Penazzato M; Prendergast A; Tierney J; Cotton M; Gibb D
Cochrane Database Syst Rev; 2012 Jul; (7):CD004772. PubMed ID: 22786492
[TBL] [Abstract][Full Text] [Related]
22. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
Mofenson LM;
MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
[TBL] [Abstract][Full Text] [Related]
23. Effect of in utero exposure to HIV and antiretroviral drugs on growth in HIV-exposed uninfected children: a systematic review and meta-analysis protocol.
Ekali GL; Jesson J; Enok PB; Leroy V
BMJ Open; 2019 Jun; 9(6):e023937. PubMed ID: 31229997
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of cognitive enhancers for Alzheimer's disease: protocol for a systematic review and network meta-analysis.
Tricco AC; Vandervaart S; Soobiah C; Lillie E; Perrier L; Chen MH; Hemmelgarn B; Majumdar SR; Straus SE
Syst Rev; 2012 Jun; 1():31. PubMed ID: 22742585
[TBL] [Abstract][Full Text] [Related]
25. Screening for HIV Infection in Pregnant Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Selph SS; Bougatsos C; Dana T; Grusing S; Chou R
JAMA; 2019 Jun; 321(23):2349-2360. PubMed ID: 31184704
[TBL] [Abstract][Full Text] [Related]
26. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
27. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
28. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
Mbuagbaw L; Mursleen S; Irlam JH; Spaulding AB; Rutherford GW; Siegfried N
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD004246. PubMed ID: 27943261
[TBL] [Abstract][Full Text] [Related]
29. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
[TBL] [Abstract][Full Text] [Related]
30. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
Gibb DM; Kizito H; Russell EC; Chidziva E; Zalwango E; Nalumenya R; Spyer M; Tumukunde D; Nathoo K; Munderi P; Kyomugisha H; Hakim J; Grosskurth H; Gilks CF; Walker AS; Musoke P;
PLoS Med; 2012; 9(5):e1001217. PubMed ID: 22615543
[TBL] [Abstract][Full Text] [Related]
31. Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis.
Uthman OA; Nachega JB; Anderson J; Kanters S; Mills EJ; Renaud F; Essajee S; Doherty MC; Mofenson LM
Lancet HIV; 2017 Jan; 4(1):e21-e30. PubMed ID: 27864000
[TBL] [Abstract][Full Text] [Related]
32. Interventions for preventing late postnatal mother-to-child transmission of HIV.
Horvath T; Madi BC; Iuppa IM; Kennedy GE; Rutherford G; Read JS
Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD006734. PubMed ID: 19160297
[TBL] [Abstract][Full Text] [Related]
33. Adverse fetal and infant outcomes among HIV-infected women who received either nonnucleoside reverse transcriptase inhibitor-based or protease inhibitor-based antiretroviral therapy for prevention of mother-to-child transmission.
Masaba R; Borkowf CB; Girde S; Zeh C; Ndivo R; Nyang'au I; Achola K; Thomas TK; Lecher SL
AIDS; 2018 Jul; 32(12):1625-1632. PubMed ID: 30001243
[TBL] [Abstract][Full Text] [Related]
34. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?
Thorne C; Newell ML
Drug Saf; 2007; 30(3):203-13. PubMed ID: 17343429
[TBL] [Abstract][Full Text] [Related]
35. Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis.
Siemieniuk RA; Foroutan F; Mirza R; Mah Ming J; Alexander PE; Agarwal A; Lesi O; Merglen A; Chang Y; Zhang Y; Mir H; Hepworth E; Lee Y; Zeraatkar D; Guyatt GH
BMJ Open; 2017 Sep; 7(9):e019022. PubMed ID: 28893758
[TBL] [Abstract][Full Text] [Related]
36. Antiviral efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV-infected children and adolescents: a systematic review protocol.
Adetokunboh OO; Schoonees A; Wiysonge CS
Syst Rev; 2014 Aug; 3():87. PubMed ID: 25115243
[TBL] [Abstract][Full Text] [Related]
37. Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children.
Heidari S; Mofenson L; Cotton MF; Marlink R; Cahn P; Katabira E
J Acquir Immune Defic Syndr; 2011 Aug; 57(4):290-6. PubMed ID: 21602695
[TBL] [Abstract][Full Text] [Related]
38. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.
Floridia M; Mastroiacovo P; Tamburrini E; Tibaldi C; Todros T; Crepaldi A; Sansone M; Fiscon M; Liuzzi G; Guerra B; Vimercati A; Vichi F; Vicini I; Pinnetti C; Marconi AM; Ravizza M;
BJOG; 2013 Nov; 120(12):1466-75. PubMed ID: 23721372
[TBL] [Abstract][Full Text] [Related]
39. Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis.
Tricco AC; Soobiah C; Antony J; Hemmelgarn B; Moher D; Hutton B; Straus SE
Syst Rev; 2013 Jun; 2():46. PubMed ID: 23810058
[TBL] [Abstract][Full Text] [Related]
40. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
